{"id":5014,"date":"2026-10-09T11:17:49","date_gmt":"2026-10-09T03:17:49","guid":{"rendered":"https:\/\/pharma-reliance.com\/?p=5014"},"modified":"2026-10-09T11:17:49","modified_gmt":"2026-10-09T03:17:49","slug":"interpretation-of-gmp-equipment-requirements-and-full-lifecycle-qualification-and-validation-%e3%80%90-part-2%e3%80%91","status":"publish","type":"post","link":"https:\/\/pharma-reliance.com\/pt\/interpretation-of-gmp-equipment-requirements-and-full-lifecycle-qualification-and-validation-%e3%80%90-part-2%e3%80%91\/","title":{"rendered":"Interpretation of GMP Equipment Requirements and Full Lifecycle Qualification and Validation \u3010 PART -2\u3011"},"content":{"rendered":"

China GMP Chapter VII: Validation and Qualification<\/strong><\/h4>\n

Article 138: Enterprises shall determine the qualification or validation activities required to demonstrate that the critical elements of relevant operations can be effectively controlled.<\/p>\n

The scope and extent of qualification or validation shall be determined through risk assessment.<\/p>\n

Article 139: An enterprise’s premises, facilities, equipment, and testing instruments shall be qualified; production, operations, and testing shall be conducted using validated production processes, standard operating procedures, and testing methods; and a validated state shall be maintained.<\/p>\n

Article 140: Documentation and records for qualification and validation shall be established to demonstrate that the following predetermined objectives have been achieved:<\/p>\n

(i) Design Qualification (DQ) shall demonstrate that the design of premises, facilities, and equipment meets the intended use and the requirements of these Good Manufacturing Practices;<\/p>\n

(ii) Installation Qualification (IQ) shall demonstrate that the construction and installation of premises, facilities, and equipment comply with design standards;<\/p>\n

(iii) Operational Qualification (OQ) shall demonstrate that the operation of premises, facilities, and equipment complies with design standards;<\/p>\n

(iv) Performance Qualification (PQ) shall demonstrate that premises, facilities, and equipment consistently meet standards under normal operating methods and process conditions;<\/p>\n

(v) \u200b\u200bProcess Validation shall demonstrate that a production process, when operated according to specified process parameters, consistently yields products that meet the intended use and registration requirements.<\/p>\n

Regarding equipment, the core consists of four stages: Design Qualification (DQ), Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ). These stages progress sequentially to ultimately demonstrate that the equipment is suitable for its intended use and complies with regulatory and quality requirements.<\/p>\n

A corresponding risk assessment should be conducted prior to qualification, in accordance with the GMP requirement to “conduct qualification and validation based on risk.” Risk assessment serves as a tool to guide the scope and depth of DQ (and all subsequent qualification activities).<\/p>\n

For specific assessment details, please refer to the ISPE Commissioning & Qualification (C&Q) guidelines. The “System Risk Assessment” (SRA) in the *Baseline Guide* (2nd Edition) focuses on quality and functionality. It begins with the product’s Critical Quality Attributes (CQAs) and Critical Process Parameters (CPPs), then proceeds to analyze the equipment’s process functions to determine which functions are essential for ensuring quality and which design elements are core to achieving those functions. (This differs from the 1st Edition’s CCA\u2014Component Criticality Assessment\u2014which involved breaking equipment down into individual components to assess whether component failure, contamination, or design deviation would directly impact product quality. While SRA has replaced CCA, they can be used in combination; however, most implementations now utilize the new requirement templates.)<\/p>\n

 <\/p>\n

\"\"<\/p>\n

 <\/p>\n

The assessment requires distinguishing between “Direct Impact Systems” and “No-Impact Systems.” The guide lists eight questions (Q1\u2013Q8) for making this determination; as the details are extensive, they will not be elaborated upon here (an assessment template is provided in Section 4.4 of the guide).<\/p>\n

 <\/p>\n

\"\"<\/p>\n

<\/h4>\n

<\/h4>\n

\"\"<\/strong><\/h4>\n

Direct Impact Systems:<\/strong><\/h4>\n

01) Design Qualification (DQ)<\/h4>\n

User Requirement Specifications (URS) are prepared based on the manufacturing process, quality control, and GMP compliance requirements. The equipment’s design parameters, materials of construction, structure, control systems, and compatibility with cleaning and sterilization processes are compared against the URS for compliance. Verification is based on documents such as design drawings, technical specifications, equipment selection justifications, and cleaning analyses. This process takes place during the design or selection phase, serving as the foundational stage. The equipment’s functions, technical parameters, materials, and safety design are verified against the URS to ensure full compliance with the intended use and GMP requirements.<\/p>\n

For many mature, common types of equipment, suppliers often provide standardized DQ templates or even pre-filled comparison documents as a value-added service to enhance efficiency. However, the manufacturing enterprise must remain vigilant, as it bears the primary responsibility for pharmaceutical production.<\/p>\n

While the supplier’s perspective focuses on the equipment meeting standard specifications, the enterprise can\u2014and should\u2014require modifications to specific aspects of the equipment based on actual operational scenarios, such as specific product characteristics, facility layout, cleanroom classification, risks associated with multi-product (shared-line) manufacturing, and ease of operator use.<\/p>\n

02) Installation Qualification (IQ)<\/h4>\n

Performed after the equipment has been delivered and installed; the core focus is “verifying hardware and supporting components.” Verify that the model numbers of equipment, components, and instruments match the order specifications; inspect the installation environment (cleanliness class, spatial layout, utilities, temperature\/humidity) and installation method for correctness, and ensure all hardware is complete; confirm the completeness of archived technical documentation (manuals, material certificates, instrument factory calibration certificates, as-built drawings, certificates of conformity, etc.); complete equipment labeling and initial status checks, perform initial calibration on instruments requiring it, and confirm that the installation meets specifications.<\/p>\n

03) Operational Qualification (OQ)<\/h4>\n

Verify\u2014under no-load or simulated-load conditions\u2014that all equipment functions operate normally and that parameter ranges meet design requirements, focusing on “testing limits and functionality.” Test equipment functions item by item (start\/stop, parameter adjustment, alarm interlocks, safety protections, etc.) and confirm normal operation; calibrate critical instruments and measuring devices to ensure accuracy meets requirements; test the adjustable ranges of critical process parameters and verify stable coverage of the required upper and lower limits (e.g., maximum\/minimum temperature, rotational speed); and verify alarm and emergency stop functions, power recovery, access control, cleaning confirmation, and the suitability of routine maintenance procedures.<\/p>\n

04) Performance Qualification (PQ)<\/h4>\n

PQ confirms the equipment’s performance stability during long-term operation under simulated or actual production conditions, ensuring the consistent output of compliant products. Operations are conducted continuously for at least three batches using actual production materials or equivalent substitutes, adhering to established production process parameters. PQ is often performed concurrently with process validation; however, if process requirements differ significantly between products, subsequent qualification may be required. Key operating parameters are monitored throughout the process to verify equipment stability, reproducibility, and parameter fluctuation ranges. Comprehensive quality testing is performed on the output from various qualification runs to confirm compliance with predetermined quality standards (referencing the product’s In-Process Control [IPC] and finished product testing standards).<\/p>\n

Additionally, specific prerequisites must be met before commencing PQ: confirm that IQ and OQ have been completed and approved; verify that all critical instruments are within their calibration validity periods; ensure that relevant SOPs for equipment operation and maintenance are in effect; and confirm that test materials and inspection methods are ready and compliant. Based on prior system risk assessment reports, demonstrate that all PQ test items, sampling points, and acceptance criteria comprehensively cover identified high-risk areas and that risk control measures are verified through this performance qualification.<\/p>\n

 <\/p>\n

Summary:<\/h4>\n

The above discussion covers two main aspects: a breakdown of the four-stage equipment qualification system\u2014DQ (Design Qualification), IQ (Installation Qualification), OQ (Operational Qualification), and PQ (Performance Qualification)\u2014detailing their core objectives and activities, as well as the progressive logic and regulatory basis for each stage.<\/p>\n

It includes a clause-by-clause study of GMP regulations regarding equipment, covering five key modules: Principles, Design & Installation, Maintenance & Repair, Operation & Cleaning, and Calibration.<\/p>\n

It clarifies the core principles of equipment management: Closed-loop management (ensuring procedures, records, and traceability across the entire lifecycle\u2014design, installation, use, maintenance, calibration, changes, and deviations); Scientific validation (defining the depth of validation based on risk assessment, balancing compliance with efficiency); and Data integrity (ensuring all qualification data is authentic, traceable, and compliant with data reliability requirements).<\/p>\n","protected":false},"excerpt":{"rendered":"

China GMP Chapter VII: Validation and Qualification Article 138: Enterprises shall determine the qualification or validation activities required to demonstrate […]<\/p>\n","protected":false},"author":1,"featured_media":5017,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_angie_page":false,"postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"page_builder":"","footnotes":""},"categories":[58],"tags":[],"class_list":["post-5014","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gmp-fda-validation"],"_links":{"self":[{"href":"https:\/\/pharma-reliance.com\/pt\/wp-json\/wp\/v2\/posts\/5014","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-reliance.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-reliance.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-reliance.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-reliance.com\/pt\/wp-json\/wp\/v2\/comments?post=5014"}],"version-history":[{"count":3,"href":"https:\/\/pharma-reliance.com\/pt\/wp-json\/wp\/v2\/posts\/5014\/revisions"}],"predecessor-version":[{"id":5021,"href":"https:\/\/pharma-reliance.com\/pt\/wp-json\/wp\/v2\/posts\/5014\/revisions\/5021"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharma-reliance.com\/pt\/wp-json\/wp\/v2\/media\/5017"}],"wp:attachment":[{"href":"https:\/\/pharma-reliance.com\/pt\/wp-json\/wp\/v2\/media?parent=5014"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-reliance.com\/pt\/wp-json\/wp\/v2\/categories?post=5014"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-reliance.com\/pt\/wp-json\/wp\/v2\/tags?post=5014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}